Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory

Authors
Jin, YerinYu, SoraLiu, Jing-JingYun, Eun JuLee, Jae WonJin, Yong-SuKim, Kyoung Heon
Issue Date
18-8월-2021
Publisher
BMC
Keywords
BpGH16A; CRISPR-Cas9; Neoagarooligosaccharides; Prebiotics; Probiotics; Saccharomyces boulardii
Citation
MICROBIAL CELL FACTORIES, v.20, no.1
Indexed
SCIE
SCOPUS
Journal Title
MICROBIAL CELL FACTORIES
Volume
20
Number
1
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/136839
DOI
10.1186/s12934-021-01644-w
ISSN
1475-2859
Abstract
Background: Saccharomyces cerevisiae var. boulardii is a representative probiotic yeast that has been widely used in the food and pharmaceutical industries. However, S. boulardii has not been studied as a microbial cell factory for producing useful substances. Agarose, a major component of red macroalgae, can be depolymerized into neoagarooligosaccharides (NAOSs) by an endo-type beta-agarase. NAOSs, including neoagarotetraose (NeoDP4), are known to be health-benefiting substances owing to their prebiotic effect. Thus, NAOS production in the gut is required. In this study, the probiotic yeast S. boulardii was engineered to produce NAOSs by expressing an endo-type beta-agarase, BpGH16A, derived from a human gut bacterium Bacteroides plebeius. Results: In total, four different signal peptides were compared in S. boulardii for protein (BpGH16A) secretion for the first time. The SED1 signal peptide derived from Saccharomyces cerevisiae was selected as optimal for extracellular production of NeoDP4 from agarose. Expression of BpGH16A was performed in two ways using the plasmid vector system and the clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9 system. The production of NeoDP4 by engineered S. boulardii was verified and quantified. NeoDP4 was produced by S. boulardii engineered using the plasmid vector system and CRISPR-Cas9 at 1.86 and 0.80 g/L in a 72-h fermentation, respectively. Conclusions: This is the first report on NAOS production using the probiotic yeast S. boulardii. Our results suggest that S. boulardii can be considered a microbial cell factory to produce health-beneficial substances in the human gut.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Life Sciences and Biotechnology > Division of Food Bioscience and Technology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Kyoung Heon photo

Kim, Kyoung Heon
융합생명공학과
Read more

Altmetrics

Total Views & Downloads

BROWSE